Correction to: Metabolites involved in purine degradation, insulin resistance, and fatty acid oxidation are associated with prediction of Gestational diabetes in plasma (Metabolomics, (2021), 17, 12, (105), 10.1007/s11306-021-01857-5)

Lauren E. McMichael, Hannah Heath, Catherine M. Johnson, Rob Fanter, Noemi Alarcon, Adilene Quintana-Diaz, Kari Pilolla, Andrew Schaffner, Elissa Jelalian, Rena R. Wing, Alex Brito, Suzanne Phelan, Michael R. La Frano*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

In the original publication of the article, excess supplementary files were published inadvertently as ESM. However, it has now been updated in the original article. The erratum is published just to notify this to the readers. The original article has been corrected.

Original languageEnglish
Article number4
JournalMetabolomics
Volume18
Issue number1
DOIs
StatePublished - 2022
Externally publishedYes

Bibliographical note

Publisher Copyright:
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Clinical Biochemistry

Fingerprint

Dive into the research topics of 'Correction to: Metabolites involved in purine degradation, insulin resistance, and fatty acid oxidation are associated with prediction of Gestational diabetes in plasma (Metabolomics, (2021), 17, 12, (105), 10.1007/s11306-021-01857-5)'. Together they form a unique fingerprint.

Cite this